Effect of glucocorticoid hormone on nuclear matrix in cervical cancer cells in vitro

Anticancer Research

Volumn 18, Issue 1 A, 1998, Pages 209-216

  Yam, H F ^a   Wang, Z H ^a   Or, P C ^a   Wang, S W ^a   Li, J ^b   Chew, E C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cell culture; Cervical cancer cell line; Dexamethasone; HPV16 E7; Immunohistochemistry; Nuclear matrix; RT PCR; Western blotting

Indexed keywords

DEXAMETHASONE; NUCLEAR PROTEIN; ONCOPROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL DIFFERENTIATION; CELL KINETICS; CELL NUCLEUS MATRIX; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; UTERINE CERVIX CARCINOMA; UTERINE CERVIX EPITHELIUM; WART VIRUS;

CARCINOMA; CELL DIVISION; DEXAMETHASONE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; GLUCOCORTICOIDS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; KI-67 ANTIGEN; NUCLEAR MATRIX; ONCOGENE PROTEINS, VIRAL; RNA, NEOPLASM; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0031920295     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Yam HF, Chew EC, Yang L, Chew-Chen SB, Ding MX: Human papillomavirus type 16 DNA integration in nuclear matrix and chromosome scaffold associated DNA in a cervical carcinoma cell line. Oncol Rep 2: 1093-1096, 1995.
2. Yam HF, Chen HB, Yang L, Wang SW, Cheng-Chew SB, Wang ZH, Chew EC: Human papillomavirus 16 E6 and E7 are associated with the nuclear matrix of cervical carcinoma cells. Oncol Rep 4: 543-547, 1995.
3. Vousden KH: Human papillomavirus and cervical carcinoma. Cancer Cells 1: 43-50, 1989.
4. Brinton LA. 1992. Epidemiology of cervical cancer - overview. In: The Epidemiology of Cervical Cancer and Human Papillomavirus. Munoz N et al (eds.). Lyon IARC Scientific Publications. pp3-22.
5. Schneider-Maunoury S, Croissant O, Orth G: Integration of human papillomavirus type 16 DNA sequences: a possible early event in the progression of genital tumours. J Virol 61: 3295-3298, 1987.
6. Pater MM, Mittal KR, Pater A: Role of steroid hormones in potentiating transformation of cervical cells by human papillomaviruses. Trends Microbiol 2: 229-34, 1994.
7. Mittal R, Pater A, Pater MM: Multiple HPV type 16 glucocorticoid response element functional for transformation, transient expression and DNA-protein interactions. J Virol 67: 5656-5659, 1993.
8. Khare S, Kumar KU, Tang SC, Pater MM, Pater A: Up-regulation of hormone response of human papillomavirus 16 expression and increased DNA-protein binding by consensus mutations of viral glucocorticoid response elements. J Med Virol 50: 254-262, 1996.
9. Sexton CJ, Proby CM, Banks L, Stables JN, Powell K, Navsaria H, Leigh IM: Characterization of factors involved in human papillomavirus type 16-mediated immortalization of oral keratinocytes. J Gen Virol 74: 755-761, 1993.
10. Maroder M, Martinotti S, Vacca A, Screpanti I, Petrangeli E, Frati L, Gulino A, 1990. Post-transcriptional control of c-myc proto-oncogene expression by glucocorticoid hormones in human T-lymphoblastic leukaemia cells. Nucleic Acids Res. 18(5): 1153-7.
11. Rosen M, Auborn K 1991. Duplication of the upstream regulatory sequences increases the transformation potential of human papillomavirus type 11. Virology 185: 484-487.
12. Spitkovsky D, Aengeneyndt F, Braspenning J, von Knebel Doeberitz M: p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene. Oncogene 13: 1027-1035, 1996.
13. von Knebel Doeberitz M, Oltersdorf T, Schwarz E, Gissmann L: Correlation of modified human papillomavirus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res 48: 3780-3786, 1988.
14. Ho TH, Chew EC, Tam JSL, Hou HJ, Yam HF, Cheng-Chew SB, Wong FWS: Biological characteristics of a newly established human cervical carcinoma cell line. Anticancer Res 13: 967-972, 1993.
15. Fey EG, Penman S: Nuclear matrix proteins reflect cell type of origin in cultured human cells. Proc Natl Acad Sci USA 85: 121-125, 1988.
16. Yang L, Yam HF, Cheng-Chew SB, Wang SW, Loong EPL, Chew EC: Association of HPV16 DNA with specific nuclear matrix proteins of normal and cervical carcinoma cells. Anticancer Res 17: 343-348, 1997.
17. Guinebretiere JM, Sabourin JC: Ki-67, marker of proliferation. Ann Pathol 17(1): 25-30, 1997.
18. Hsu HL, Yeh NH: Dynamic changes of NuMA during the cell cycle and possible appearance of a truncated form of NuMA during apoptosis. J Cell sci 109(2): 277-288, 1996.
19. Sundstrom BE, Stigbrand TI: Cytokeratins and tissue polypeptide antigen. Int J Biol Markers 9(2): 102-108, 1994.
20. Greenfield I, Nickerson J, Penman S, Stanley M: Human papillomavirus 16 E7 proteins are associated with the nuclear matrix, Proc Natl Acad sci USA 88: 11217-11221, 1991.
21. Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R: The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63(10): 4417-4421, 1989.
22. Romanczuk H, Villa LL, Schlegel R, Howley PM: The viral transcriptional regulatory region upstream of the E6 and E7 gene is the major determinant of the differential immortalization activities of human papillomavirus types 16 and 18. J Virol 65(5): 2739-2744, 1991.
23. Werness BA, Levine AJ, Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 248: 76-9, 1990.
24. Scheffner M, Werness BA, Hibregtse JM, Levine AJ, Howley PM: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136, 1990.
25. Lechner MS, Mack DH, Finicle AB, Crook T, Vousden KH, Laimins LA: Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53 mediated repression of transactivation. EMBO J 11: 3045-3052, 1992.
26. Munger K, Werness BA, Dyson N, Phelps WC, Howley PM: Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumour suppressor gene product. EMBO J 8: 4099-4105, 1989.
27. Boyer SN, Wazer DE, Band V: E7 protein of human papillomavirus 16 induces degradation of retinoblastoma proteins through the ubiquitin-proteasome pathway. Cancer Res 56: 4620-4624, 1996.
28. Wu EW, Clemenens KR, Heck DV, Munger K: The human papillomavirus E7 oncoprotein and the cellular transcriptional factor E2F bind to separate sites on the retinoblastoma tumour suppressor protein. J Virol 67: 2402-2407, 1993.
29. Hiraiwa A, Kiyono T, Suzuki S, Ohashi M, Ishibashi M: E7 proteins of four groups of HPVs, irrespective of their tissue tropism or cancer association, possess the ability to transactivate transcriptional promoters E2F site dependently. Virus Genes 12: 27-35, 1996.
30. Mancini MA, Shan B, Nickerson JA, Penman S, Lee WH: The retinoblastoma gene product is cell-cycle dependent, nuclear matrix associated protein. Proc Natl Acad sci USA 91: 418-422, 1994.
31. Mirkovitch J, Mirault ME, Laemmli UK: Organization of the higher order chromatin loop: specific DNA attachment sites on nuclear scaffold. Cell 39: 223-232, 1994.
32. Ciejek EM, Tsai MJ, Oalley BW: Actively transcribed genes are associated with the nuclear matrix. Nature 306: 607-309, 1983.
33. Vaughn JP, Dijkwel PA, Mullenders LHF, Hamlin JL: Replication forks are associated with the nuclear matrix. Nucleic Acids Res 18: 1965-1969, 1990.
34. Smith HC, Berezney R: DNA polymerase α is tightly bound to the nuclear matrix of actively replicating liver. Biochem Biophys Res Comm. 97(4): 1541-1547, 1980.
35. Eisenman RN, Tachibana CY, Abrarns HD, Hann SR: V-myc and c-myc encoded proteins are associated with nuclear matrix. Mol Cell Biol 5: 114-126, 1985.
36. Khanuja PS, Lehr JE, Soule HD, Gehani SK, Noto AC, Choudhury S, Chen R, Pienta KJ: Nuclear matrix proteins in normal and breast cancer cells. Cancer Res 53: 3394-3398, 1993.
37. Getzenberg RH, Pienta KJ, Huang EYW, Coffey DS: Identification of nuclear matrix proteins in the cancer and normal rat prostate. Cancer Res 51: 6514-20, 1991.
38. Keesee SK, Meneghini MD, Szaro RP, Wu YJ: Nuclear matrix proteins in human colon cancer. Proc Natl Acad Sci USA 91: 1913-1916, 1994.
39. Yang L, Chew EC, Cheng-Chew SB, Jiao RJ, Yam HF, Zhai ZH: Fine structural observation of a nucleolar - nuclear matrix - lamina -intermediate filament system in transformed cells. Anticancer Res 14: 1829-1832, 1994.